Heart Disease News and Research

Latest Heart Disease News and Research

ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment test

deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE's DNA-based prostate cancer risk assessment test to its clients nationwide.

20 Jul 2010

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

20 Jul 2010

Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2

Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.

20 Jul 2010

Failure to seek help for ED could prevent detection of underlying cardiovascular disease

Research carried out by a visiting professor at the University of Hertfordshire has found that up to six million European men fail to seek help for Erectile Dysfunction (ED) which could result in underlying cardiovascular disease going undetected.

20 Jul 2010

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

The flood of scientific evidence on omega-3 eicosapentaenoic acid/docosahexaenoic acid (EPA/DHA) has significantly buoyed the credibility of polyunsaturated fatty acids (PUFAs) as vital functional ingredients. Heightened consumer awareness has had a telling effect on the healthy growth charts of the marine and algae oil omega-3 ingredients market.

20 Jul 2010

Heart patients living with children exercise less: Study

A study conducted at the Montreal Heart Institute (MHI) has shown unexpectedly that living with children is linked to a reduction in physical activity. Carried out with 756 participants and led by Dr. Simon L. Bacon, Associate Researcher at the MHI and Professor at Concordia University, the study assessed the impact of social networks on exercise, revealing that people with heart disease who live with children exercise less than those people who do not live with children.

20 Jul 2010

More than half of parents interested in using at-home personal genetic testing for their children: Poll

The latest results from the C.S. Mott Children's Hospital National Poll on Children's Health show more than half of parents are interested in having their children checked for disease risks using at-home personal genetic testing kits.

20 Jul 2010

New approach to understand different cancer subtypes

An international team led by St. Jude Children's Research Hospital scientists finds unique combinations of cells and mutations lie at the heart of cancer subgroup revealed for the first time in a pediatric brain tumor

20 Jul 2010

Scientists find major shortcomings in assessing CVD risk in HIV patients

At the same time that medical science has nearly eliminated AIDS deaths in patients treated for human immunodeficiency virus, two international meetings of HIV/AIDS scientists and patient advocates find major shortcomings in the design and analysis of studies used to assess cardiovascular disease risk in people with HIV with significant implications for improving medical care.

20 Jul 2010

Case Western Reserve awarded $0.5M for study of breast cancer in older women

Cynthia Owusu, MD, associate professor at Case Western Reserve University and geriatric-oncologist at University Hospitals Case Medical Center, the School's primary affiliate, has received nearly $500,000 from Susan G. Komen For the Cure to fund a novel three-year study aimed at improving outcomes for older women with newly-diagnosed breast cancer.

20 Jul 2010

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

A Phase 3 open-label study, recently published online by Pain Practice, has compared tapentadol extended release tablets, an investigational pain medication, to an existing prescription pain medication, oxycodone controlled release tablets.

20 Jul 2010

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Evansville (Ind.) Courier & Press reports on the struggles rural physicians face in providing care by focusing on Dr. Lloyd "Pat" McGinnis, a family medicine and geriatrics specialist who was "one of only five doctors in Spencer County, a rural area of Southwestern Indiana. … Doctors throughout the country are struggling with the same issues of providing quality care to patients with limited incomes in an environment of uncertainly as major provisions of the Patient Protection and Affordable Care Act are phased in over the next five years.

20 Jul 2010

AIDS 2010 studies, releases: Treating HIV-positive patients with ARVs drove down number of new HIV infections, study finds

"Treating HIV patients with cocktails of AIDS drugs helps to stop them spreading the infection further and more than halved the number of new HIV diagnoses in a study in Canada, scientists said on Sunday," Reuters reports.

20 Jul 2010

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Here are highlights from the July issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required.

20 Jul 2010

Abortion fight again heats up over high-risk pools, other health reform news

Anti-abortion activists have "scored a victory" after a decision last week by the Obama administration to not allow the new high-risk pools in America to cover most abortions, The Associated Press reports.

20 Jul 2010

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

Research conducted by surgeons from the Methodist DeBakey Heart & Vascular Center shows that using robotics reduces blood vessel trauma during minimally invasive procedures to repair diseased arteries. Research results were presented at the Society for Vascular Surgery's 2010 Vascular Annual Meeting in Boston.

19 Jul 2010

GE Capital serves as sole lender to Mitralign for $5 million senior secured credit facility

GE Capital, Healthcare Financial Services announced today that it served as agent and sole lender to Mitralign, Inc. for a $5 million senior secured credit facility. Mitralign will use the credit facility for working capital as the company advances development of its mitral valve repair device.

19 Jul 2010

Amira achieves two clinical development milestones in FLAP program for asthma

"Amira Pharmaceuticals, Inc. announced today that its FLAP (5-lipoxygenase-activating protein) program, which is partnered with GlaxoSmithKline, has achieved two clinical development milestones."

19 Jul 2010

Geron commences enrollment in imetelstat Phase 2 clinical trial for NSCLC

Geron Corporation today announced enrollment of the first patient in a randomized Phase 2 clinical trial of its telomerase inhibitor drug, imetelstat (GRN163L), as maintenance therapy following platinum-based induction therapy for patients with non-small cell lung cancer (NSCLC).

19 Jul 2010

First Edition: July 19, 2010

Today's headlines include the latest news regarding the politics of implementing health reform as well as developments from the international AIDS conference now underway in Vienna.

19 Jul 2010

Heart Disease News and Research

Latest Heart Disease News and Research

ARUP enters partnership to offer deCODE's DNA-based prostate cancer risk assessment test

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2

Failure to seek help for ED could prevent detection of underlying cardiovascular disease

European marine and algae oil omega-3 ingredient market to grow at 10% CAGR to reach $525.6M in 2013

Heart patients living with children exercise less: Study

More than half of parents interested in using at-home personal genetic testing for their children: Poll

New approach to understand different cancer subtypes

Scientists find major shortcomings in assessing CVD risk in HIV patients

Case Western Reserve awarded $0.5M for study of breast cancer in older women

Phase 3 study: Tapentadol ER lowers incidence of gastrointestinal adverse events

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

AIDS 2010 studies, releases: Treating HIV-positive patients with ARVs drove down number of new HIV infections, study finds

Mayo Clinic's July issue offers tips on ophthalmology, Alzheimer's and CKD

Abortion fight again heats up over high-risk pools, other health reform news

Robotic therapies reduce blood vessel trauma during minimally invasive procedures

GE Capital serves as sole lender to Mitralign for $5 million senior secured credit facility

Amira achieves two clinical development milestones in FLAP program for asthma

Geron commences enrollment in imetelstat Phase 2 clinical trial for NSCLC

First Edition: July 19, 2010

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Heart Disease News and Research

Latest Heart Disease News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in